Can Genome Editing Fulfill Its Promise and Meet Unmet Medical Needs?

1:45 PM - 2:45 PM, Wednesday, June 5, 2019 ・ 118A, Level 100
Human gene editing continues to hold a major fascination within a biomedical and biopharmaceutical industries. It's extraordinary potential is now being realized but important questions as to who will be the beneficiaries of such breakthrough technologies remained to be answered. The session will discuss whether gene editing technologies can alleviate some of the most challenging unmet medical needs. We will discuss how research advances often never reach minority communities and how diverse patient populations will gain access to such breakthrough technologies. It is widely recognize that there are patient voids in the population and we will explore how community health centers might fill this void to ensure that state-of-the-art technologies can reach the forgotten patient groups . We also will touch ethical questions surrounding germline editing and how such research and development could impact the community at large.
Assoc Professor
Johns Hopkins School of Medicine
Adjunct Associate Professor of Medicine
University of Pennsylvania School of Medicine
Pediatric Oncologist, Bioethicist, Health Services Researcher
Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School